These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 28117588

  • 1. Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Astolfi A, Felicetti T, Iraci N, Manfroni G, Massari S, Pietrella D, Tabarrini O, Kaatz GW, Barreca ML, Sabatini S, Cecchetti V.
    J Med Chem; 2017 Feb 23; 60(4):1598-1604. PubMed ID: 28117588
    [Abstract] [Full Text] [Related]

  • 2. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N, Tambat R, Chandal N, Verma DK, Thakur KG, Nandanwar H.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0095121. PubMed ID: 34908453
    [Abstract] [Full Text] [Related]

  • 3. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A.
    J Med Chem; 2008 Jul 24; 51(14):4321-30. PubMed ID: 18578473
    [Abstract] [Full Text] [Related]

  • 4. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S, Gosetto F, Iraci N, Barreca ML, Massari S, Sancineto L, Manfroni G, Tabarrini O, Dimovska M, Kaatz GW, Cecchetti V.
    J Med Chem; 2013 Jun 27; 56(12):4975-89. PubMed ID: 23710549
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
    Felicetti T, Cannalire R, Pietrella D, Latacz G, Lubelska A, Manfroni G, Barreca ML, Massari S, Tabarrini O, Kieć-Kononowicz K, Schindler BD, Kaatz GW, Cecchetti V, Sabatini S.
    J Med Chem; 2018 Sep 13; 61(17):7827-7848. PubMed ID: 30067360
    [Abstract] [Full Text] [Related]

  • 8. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
    Holler JG, Slotved HC, Mølgaard P, Olsen CE, Christensen SB.
    Bioorg Med Chem; 2012 Jul 15; 20(14):4514-21. PubMed ID: 22682300
    [Abstract] [Full Text] [Related]

  • 9. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
    Naaz F, Khan A, Kumari A, Ali I, Ahmad F, Ahmad Lone B, Ahmad N, Ali Khan I, Rajput VS, Grover A, Shafi S.
    Bioorg Chem; 2021 Aug 15; 113():105031. PubMed ID: 34089943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK, Singh S, Kumar S, Wani NA, Rai R, Koul S, Khan IA, Sangwan PL.
    Bioorg Med Chem; 2019 Jan 15; 27(2):343-353. PubMed ID: 30552006
    [Abstract] [Full Text] [Related]

  • 12. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Sangwan PL, Koul JL, Koul S, Reddy MV, Thota N, Khan IA, Kumar A, Kalia NP, Qazi GN.
    Bioorg Med Chem; 2008 Nov 15; 16(22):9847-57. PubMed ID: 18848780
    [Abstract] [Full Text] [Related]

  • 13. C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors.
    Felicetti T, Mangiaterra G, Cannalire R, Cedraro N, Pietrella D, Astolfi A, Massari S, Tabarrini O, Manfroni G, Barreca ML, Cecchetti V, Biavasco F, Sabatini S.
    J Enzyme Inhib Med Chem; 2020 Dec 15; 35(1):584-597. PubMed ID: 31992093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.
    Felicetti T, Cannalire R, Nizi MG, Tabarrini O, Massari S, Barreca ML, Manfroni G, Schindler BD, Cecchetti V, Kaatz GW, Sabatini S.
    Eur J Med Chem; 2018 Jul 15; 155():428-433. PubMed ID: 29908437
    [Abstract] [Full Text] [Related]

  • 17. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.
    Wani NA, Singh S, Farooq S, Shankar S, Koul S, Khan IA, Rai R.
    Bioorg Med Chem Lett; 2016 Sep 01; 26(17):4174-8. PubMed ID: 27503686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel DiOC3 96-well real-time efflux assay for discovery of NorA efflux pump inhibitors in Staphylococcus aureus.
    Elhidar N, Nafis A, Goehler A, Abbad A, Hassani L, Mezrioui NE, Bohnert JA.
    J Microbiol Methods; 2021 Feb 01; 181():106128. PubMed ID: 33347918
    [Abstract] [Full Text] [Related]

  • 20. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A, Khan IA, Koul S, Koul JL, Taneja SC, Ali I, Ali F, Sharma S, Mirza ZM, Kumar M, Sangwan PL, Gupta P, Thota N, Qazi GN.
    J Antimicrob Chemother; 2008 Jun 01; 61(6):1270-6. PubMed ID: 18334493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.